Literature DB >> 4626239

Biological aspects of the interaction between gentamicin and carbenicillin.

J A Waitz, C G Drube, E L Moss, E M Oden, J V Bailey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4626239     DOI： 10.7164/antibiotics.25.219

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  10 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Interactions of ceftazidime and tobramycin in patients with normal and impaired renal function.

Authors:  G R Aronoff; R A Brier; R S Sloan; M E Brier
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  Radioimmunoassay of iodinated tobramycin.

Authors:  A Broughton; J E Strong; L K Pickering; G P Bodney
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

4.  Inactivation of gentamicin by penicillins in patients with renal failure.

Authors:  F R Ervin; W E Bullock; C E Nuttall
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

5.  Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics.

Authors:  R H Glew; R A Pavuk
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

6.  Inactivation of netilmicin by carbenicillin.

Authors:  D J Flournoy
Journal:  Infection       Date:  1978       Impact factor: 3.553

7.  In vitro interaction of aminoglycosides with beta-lactam penicillins.

Authors:  S M Wallace; L Y Chan
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

8.  Animal model distinguishing in vitro from in vivo carbenicillin-aminoglycoside interactions.

Authors:  J A Pieper; R A Vidal; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

9.  Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease.

Authors:  C E Halstenson; M O Wong; C S Herman; K L Heim-Duthoy; M A Teal; M B Affrime; J H Kelloway; W F Keane; W M Awni
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

10.  Hydroxylamine technique for in vitro prevention of penicillin inactivation of tobramycin.

Authors:  A J Falkowski; R J Creger
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.